|
Volumn 85, Issue 3, 2001, Pages 539-543
|
Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban
a a a |
Author keywords
Anticoagulants; Ca2+ chelation; GPIIb IIIa antagonists; Platelet aggregation
|
Indexed keywords
ABCIXIMAB;
CALCIUM ION;
CITRATE TRISODIUM;
DEXTRO PHENYLALANYLPROLYLARGINYL CHLOROMETHYL KETONE;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
THROMBIN RECEPTOR ACTIVATING PEPTIDE;
TIROFIBAN;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CALCIUM;
CHELATING AGENT;
CITRIC ACID;
DRUG DERIVATIVE;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
PEPTIDE;
TYROSINE;
ANTICOAGULATION;
ARTICLE;
BINDING AFFINITY;
CALCIUM BLOOD LEVEL;
CHELATION;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BINDING;
DRUG EFFECT;
DRUG INHIBITION;
HUMAN;
HUMAN EXPERIMENT;
IN VITRO STUDY;
IN VIVO STUDY;
NORMAL HUMAN;
PRIORITY JOURNAL;
THROMBOCYTE AGGREGATION;
THROMBOCYTE RICH PLASMA;
TURBIDIMETRY;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
KINETICS;
METABOLISM;
ANTIBODIES, MONOCLONAL;
ANTICOAGULANTS;
CALCIUM;
CHELATING AGENTS;
CITRIC ACID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
KINETICS;
PEPTIDES;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
TYROSINE;
|
EID: 0035082570
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1615618 Document Type: Article |
Times cited : (32)
|
References (20)
|